FDA-cleared profile

syngo Application Software

Siemens Medical Solutions USA, Inc. · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.

Clinical role
Diagnostic and interventional image post-processing
Images and patients
Radiological images; modality varies or is not specified in FDA list · N/A
Key limitation
Keep in mind: Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
  • Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: N/A Input: Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
  • Who uses it?Intended users: Physicians using image review and image-guided diagnosis, treatment planning or treatment control applications.
  • What does the software produce?Output: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
  • What is its most important limitation?Key limitation: Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.

Clinical takeaway. Clinical role: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.

Evidence takeaway. Evidence from the reviewed source record: FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Diagnostic and interventional image post-processing
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Diagnostic review workstations and interventional environments using Siemens angiography, fluoroscopy or radiography systems.
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Physicians using image review and image-guided diagnosis, treatment planning or treatment control applications.
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
  • Exact FDA submission
  • Checked 2026-09-05
Evidence summary
FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No comparable product-wide sensitivity is established by the option-specific processing tests.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No comparable product-wide specificity is established by the option-specific processing tests.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K254184 DynaCT Bone Removal validation

  • DesignStandalone segmentation comparison and separate clinical reader evaluation
  • Population180 reference-mask cases: 60 each thorax, abdomen and pelvis; separate 370 US/European datasets for reader evaluation
  • Scopeexact submission
  • Tested versionsyngo Application Software VE51A, DynaCT Bone Removal
  • Samplen=180
  • IndependenceSponsor or vendor study

K254184

Sample size denotes reference-mask cohort only; reader cohort is not added to it as a unique patient total.

K254184 DynaCT MORE image-quality comparison

  • DesignRetrospective comparative image-quality and diagnostic-utility reader assessment
  • Population40 image datasets assessed by two readers
  • Scopeexact submission
  • Tested versionsyngo Application Software VE51A, DynaCT MORE
  • Samplen=40
  • IndependenceSponsor or vendor study

K254184

SPINNERS

  • DesignProspective multicenter non-inferiority comparison of sine-spin flat-detector CT with multidetector CT
  • PopulationAdults with suspected ischemic or hemorrhagic stroke and feasible noncontrast syngo DynaCT Sine Spin within four hours of reference CT
  • Scopeproduct family
  • Tested versionsyngo DynaCT Sine Spin; no VE51A linkage established
  • IndependenceSponsor or vendor study

NCT05458908

University Hospital Basel sponsor with Siemens Healthineers collaborator. Registry design context only; no trial result or exact-release diagnostic performance promoted.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

Downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · syngo Application Software VE51A: K254184 clearance and summary

  2. Routing

    Source context, not route validation: Can be configured within a network to send and receive DICOM data, with syngo or Windows-based software options.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · syngo Application Software VE51A: K254184 clearance and summary

  3. AI processing

    Source context, not route validation: Independent Siemens-released PC/workstation hardware or installation on Siemens X-ray and angiography systems.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · syngo Application Software VE51A: K254184 clearance and summary

  4. Returned objects

    Source context, not route validation: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · syngo Application Software VE51A: K254184 clearance and summary

  5. Viewer/worklist/report

    Unresolved route: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · syngo Application Software VE51A: K254184 clearance and summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Independent Siemens-released PC/workstation hardware or installation on Siemens X-ray and angiography systems.
  • Exact FDA submission
  • Checked 2026-09-05
Integration
Can be configured within a network to send and receive DICOM data, with syngo or Windows-based software options.
  • Exact FDA submission
  • Checked 2026-09-05
Security
Siemens Healthineers' corporate cybersecurity page states a Secure Development Lifecycle addressing pre-market and post-market phases for products under development and a range of existing offerings; a Cybersecurity Management Service maintaining a product security inventory (over 1,000 product versions and over 21,000 monitored software components) with security whitepapers, SBOMs and vulnerability assessments available to customers via teamplay Fleet; incident and vulnerability management channels; and that Siemens Healthineers AG maintains an independent certification of its global Cybersecurity Management System to ISO/IEC 27001:2022 extended by ISO/IEC 27701:2019, with the certificate referenced to the SGS directory. Vendor statement; no certificate or report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.

Monitoring
Siemens Healthineers' cybersecurity page states that its Cybersecurity Management Service maintains a product security inventory of over 1,000 product versions and over 21,000 monitored software components, with security whitepapers, SBOMs and vulnerability assessments delivered via teamplay Fleet, and that it operates incident and vulnerability management.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.

DICOM networking

Configurable DICOM send/receive on independent workstation or supported Siemens imaging hardware.

exact submission · checked 2026-09-05

Current DynaCT option context

Vendor describes Bone Removal for adult thorax, abdomen and pelvis and MORE for motion-artifact reduction.

product family · checked 2026-09-05
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K254184
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Existing broad catalog category preserved: the software spans radiographic, fluoroscopic/angiographic and cone-beam CT applications, including ultrasound fusion; it is not solely a CT product.

Anatomy
N/A
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Existing unassigned catalog anatomy preserved because the general indication is multi-application. Individual modules address spine, cardiovascular, neurovascular, thorax, abdomen and pelvis; N/A does not mean no anatomic use.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-04-29
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
13Fields reviewed
10Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored trial metadata screened and indexed primary registry content reviewed. SPINNERS retained as family design context, not VE51A results. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, clinical trial registry, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission

    VE51A hardware, upgrade and individual-option prices were not established from reviewed sources; obtain an optionized quote.

  • Pricing model: Not verified - checked 2026-09-05 - Exact FDA submission

    Bundled versus separately licensed options and support terms remain unresolved.

  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "syngo Application Software reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-05 - Exact FDA submission

    Role-specific VE51A option training and site acceptance materials were not established.

8 sources - 3 history items

Source ledger

  1. syngo Application Software VE51A: K254184 clearance and summary

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: clinicalUse, input, output, deployment, integration, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. syngo DynaCT applications

    Siemens Healthineers - Accessed 2026-09-05

    Scope: productFamilyContext, implementationCapabilities

  7. SPINNERS: prospective evaluation of noncontrast sine-spin flat-detector CT for intracranial hemorrhage

    ClinicalTrials.gov / University Hospital Basel - Accessed 2026-09-05

    Scope: evidenceStudies, productFamilyContext

  8. Siemens Healthineers: Cybersecurity

    Siemens Healthineers - Accessed 2026-10-26

    Scope: security

Research history

  1. K254184 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K261713

Synapse PACS (7.6.0)

FUJIFILM Healthcare Americas Corporation

Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
N/A
Decision
2026-06-18
FDA-cleared K252708

Relu Cloud

Relu BV

Authorized purpose: Relu Cloud manages, transfers, analyzes, displays, enhances, and stores oral and maxillofacial images and provides design input for dental solutions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Oral and maxillofacial anatomy
Decision
2026-04-10
FDA-cleared K250237

InferOperate Suite

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Authorized purpose: InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's machine-learning functions applied to adult chest, abdomen, and pelvis CT.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest; abdomen; pelvis; and general patient anatomy represented in supported images
Decision
2025-09-15
FDA-cleared K250005

Clever One

Ewoosoft Co., Ltd

Authorized purpose: Clever One is dental imaging software for trained professionals to view and interpret DICOM images from CT, panoramic, cephalometric, intraoral, and other imaging equipment, with two-dimensional analysis and three-dimensional visualization tools.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Dental and craniomaxillofacial anatomy
Decision
2025-05-23

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history